$4.48
0.112.52%
At close: Dec 16, 4:00 PM EST
$4.53
0.051.12%
After Hours: 5:01 PM EST
Comments
Loading...
Foghorn Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:FHTX | Benzinga
Foghorn Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 5
EPS Estimate
$-0.300
Quarterly Revenue Estimate
$9.08M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$24.52M
Analyze the earnings history of Foghorn Therapeutics using advanced sorting and filters.
Foghorn Therapeutics (FHTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $-0.25 | $-0.30 | 16.7 % |
| Q2 | 2025-08-05 | $-0.28 | $-0.31 | 9.68 % |
| Q1 | 2025-05-14 | $-0.30 | $-0.24 | -25.0 % |
| Q4 | 2025-03-06 | $-0.23 | $-0.27 | 14.8 % |
Foghorn Therapeutics (FHTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-05 | $8.15M | $6.94M | 17.4 % |
| Q2 | 2025-08-05 | $7.56M | $7.31M | 3.43 % |
| Q1 | 2025-05-14 | $5.95M | $5.45M | 9.21 % |
| Q4 | 2025-03-06 | $2.86M | $8.14M | -64.9 % |
FAQ
When is Foghorn Therapeutics (NASDAQ:FHTX) reporting earnings?
Foghorn Therapeutics (FHTX) is scheduled to report earnings on March 5, 2026. The last reported earnings were for reported on November 5, 2025 for Q3.
What were the latest earnings per share (EPS) for Foghorn Therapeutics (NASDAQ:FHTX)?
The Actual EPS was $-0.25, which beat the estimate of $-0.30.
What were Foghorn Therapeutics’s (NASDAQ:FHTX) revenues?
The Actual Revenue was $8.2M, which beat the estimate of $6.9M.
Browse earnings estimates, EPS, and revenue on all stocks.
